Italy: average price of branded drugs which became off patent 2016, by brand

This statistic displays the average price of the major branded drugs, which became off patent in 2017, in Italy as of 2016. According to data, Bosentan and Velganciclovir were the branded medicines with the highest price. The cheapest branded drugs were instead, Rupatadina and Tramadolo.

Average price of the major branded drugs, which became off patent in Italy as of 2016, by brand

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2017

Region

Italy

Survey time period

2016

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical market in Italy"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.